Market Newsdesk

DALLAS, April 16, 2025 (GLOBE NEWSWIRE) — Triumph Financial, Inc. (Nasdaq: TFIN) has released its first quarter 2025 financial results. The 1Q 2025 financial results and shareholder letter are available on the Company’s website at tfin.com through the News & Events, Events & Presentations links.

Aaron P. Graft, Vice Chairman & CEO, and Brad Voss, CFO, will review the financial results in a conference call with investors and analysts beginning at 9:30 a.m. central time on Thursday, April 17, 2025.

The live video conference option may be accessed directly through this link, https://triumph-financial-q1-2025-earnings.open-exchange.net/ or via the Company’s website at tfin.com through the News & Events, Events & Presentations links. Alternatively, a live conference call option is available by dialing 1-833-928-4610 (International: 1-800-456-1369) requesting to be joined to meeting ID 970 6106 3843 at the prompt. An archive of this conference call will subsequently be available at this same location, referenced above, on the Company’s website.

About Triumph

Triumph Financial, Inc. (Nasdaq: TFIN) is a financial holding company focused on payments, factoring, intelligence and banking. Headquartered in Dallas, Texas, its diversified portfolio of brands includes TriumphPay, Triumph, TBK Bank and LoadPay.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. Investors are cautioned that such statements are predictions and that actual events or results may differ materially. Triumph Financial’s expected financial results or other plans are subject to a number of risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” and the forward-looking statement disclosure contained in the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on February 11, 2025. Forward-looking statements speak only as of the date made and Triumph Financial undertakes no duty to update the information.

Source: Triumph Financial, Inc.

Investor Relations:
Luke Wyse
Senior Vice President, Head of Investor Relations
[email protected]
214-365-6936

Media Contact:

Amanda Tavackoli
Senior Vice President, Director of Corporate Communication
[email protected]
214-365-6930

Canon Internship 2025

A Media Snippet accompanying this announcement is available by clicking on this link.

NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) — Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, today announced the return of its annual Editorial Photography Internship Program, created to nurture the next generation of visual storytellers. With support from Getty Images’ long-standing imaging partner, Canon U.S.A., Inc., a leader in digital imaging solutions, the program offers three paid internship opportunities in the United States, focused on News, Sport, and Entertainment photography.

Selected interns will work alongside Getty Images’ world-class photographers, videographers, editors, and content experts. Through immersive, real-world assignments, interns will gain first-hand experience covering editorial and commercial events, while receiving professional mentorship and access to networking opportunities. Participants will also use Canon’s EOS cameras and RF lenses – provided through Getty Images’ partnership with Canon as a preferred digital imaging equipment supplier – for both still and video capture.

The inaugural cohort – Luke Hales (Sport), Kayla Bartkowski (News), Maya Spach (Entertainment) – quickly became an integral part of the editorial team, harnessing their creative talent to cover a variety of premier events, as well as learning the intricacies of editing, event production, client relations and event systems. Their work spanned the Olympics Games Paris 2024, 2024 World Series, 67th GRAMMY Awards^®, 31st Annual Screen Actors Guild Awards^®, U.S. Presidential Inauguration week and the Ronald Reagan Washington National Airport midair collision aftermath in March 2025. Their work has been featured in hundreds of global media outlets, including ESPN, The New York Times, The Washington Post, Vanity Fair, Vogue, CNN, Axios, USA Today and The Hollywood Reporter.

Speaking about the program, Getty Images’ Global Head of Editorial Ken Mainardis says, “After a successful first year, we are excited to welcome a new group of talented interns into the fold. With Canon’s continued support, this program provides rare, behind-the-scenes access to our editorial engine–offering mentorship, resources, and hands-on opportunities to shape the next generation of visual storytellers. Our shared mission to support emerging talent and elevate impactful storytelling is at heart the of this initiative.”

“It’s important to empower the next generation of photographers and help provide support for their professional development,” said Hiroto Kato, Vice President, Business Planning & Strategy, Canon. “We are excited to continue to team up with Getty Images to assist with their editorial photography internship program as we provide the tools to aid these talented students in reaching their potential.”

Applicants for the internship program must be 18 years or older at the time of application. The internships will be based in Los Angeles (Entertainment), New York (Sport) and Washington D.C.(News). They must also be passionate about storytelling and content creation and eager to learn and display a sense of professionalism, although no professional portfolio or experience is required. While the internship is open to all applicants, Getty Images recognizes that people of color and those with intersectional identities are underrepresented in photography and are particularly encouraged to apply. The final three candidates will be announced throughout 2025.

The interns will work as part of Getty Images’ editorial team and will be paid hourly. They will be trained on all facets of the editorial photography business, including but not limited to:

• Capturing editorial content (photography and videography) from wide-ranging assignments within News, Sport and Entertainment,
• Assigning events and client relations,
• Video and field photo editing,
• Editorial still and video workflow and technique,
• Major event production and technology,
• Solo assignments as well as group assignments with editing support,
• Visual storytelling from all angles using Canon’s cutting-edge camera equipment and advanced technologies, and more.

Upon successful completion of the internships in 2026, the interns will be:

• Guaranteed portfolio and media placement,
• Provided with a professional recommendation from Getty Images,
• Added to Getty Images’ “preferred provider” list and/or considered for a staff position (if available and applicable).

To learn more about these internship opportunities and to apply, head to:

• Sport (May 15, 2025-February 15, 2026):
  https://jobs.lever.co/gettyimages/1e0aa0fd-ad2b-4da2-b0c9-08cfe275cb89
• Entertainment (September 1, 2025-May 31, 2026):
  Note, this job application will be available at a later date.
• News (September 1, 2025-May 31, 2026):
  Note, this job application will be available at a later date.
  

Media Contact:

Jenna Attardi
[email protected]

PEMBROKE, Bermuda, April 16, 2025 (GLOBE NEWSWIRE) — James River Group Holdings, Ltd. (“James River” or the “Company”) (NASDAQ: JRVR) today announced that Bob Zimardo has been appointed Senior Vice President, Investments and Investor Relations, effective April 16, 2025. He will report directly to Sarah Doran, Chief Financial Officer of the Company.

As Senior Vice President, Investments and Investor Relations, Mr. Zimardo will be responsible for investments and investor relations activity. He brings over 20 years of experience spanning asset management, investor relations, and corporate operations across both private and public global markets. Most recently he was with International Farming, a multi-billion dollar farmland investment platform, where he served as Partner, Investor Relations and Operations. Prior to International Farming, Mr. Zimardo was the Director of Client Services at Halcyon Capital Management (now Bardin Hill Investment Partners), managing relationships across a diverse set of private market investment offerings.

Ms. Doran commented, “We are excited that Bob has joined the James River finance team, and I personally look forward to working with him in his new role. He brings significant experience in investor relations and alternative investments and will be a key partner for all of us in working with our external stakeholders. I am confident that he will be very successful in his new role.”

About James River Group Holdings, Ltd.

James River Group Holdings, Ltd. is a Bermuda-based insurance holding company that owns and operates a group of specialty insurance companies. The Company operates in two specialty property-casualty insurance segments: Excess and Surplus Lines and Specialty Admitted Insurance. Each of the Company’s regulated insurance subsidiaries are rated “A-” (Excellent) by A.M. Best Company. Visit James River Group Holdings, Ltd. on the web at www.jrvrgroup.com.

Zachary Shytle
Senior Analyst, Investor Relations and Investments
(980) 249-6848
[email protected]

LITTLE ROCK, Ark., April 16, 2025 (GLOBE NEWSWIRE) — Bank OZK (the “Bank”) (Nasdaq: OZK) today announced that net income available to common stockholders for the first quarter of 2025 was $167.9 million, a 2.1% decrease from $171.5 million for the first quarter of 2024. Diluted earnings per common share for the first quarter of 2025 were $1.47, a 2.6% decrease from $1.51 for the first quarter of 2024.

George Gleason, Chairman and Chief Executive Officer, stated, “We are pleased to report our first quarter 2025 results, which provide a solid start to the year. Our talented, entrepreneurial and veteran management team is well suited for today’s very noisy and complicated economic environment. During the quarter just ended, our team has proactively and effectively managed the various challenges, uncertainties and volatilities of this environment while capitalizing on numerous promising opportunities. We are excited about the future and continue to be laser-focused on improving our performance every day.”

MANAGEMENT COMMENTS, FINANCIAL SUPPLEMENT AND CONFERENCE CALL

In connection with this release, the Bank released its management comments on its quarterly results and a financial supplement, which are available at ir.ozk.com.

Management will conduct a conference call to take questions at 7:30 a.m. CT (8:30 a.m. ET) on Thursday, April 17, 2025. Interested parties may access the conference call live via webcast on the Bank’s investor relations website at this link, or may participate via telephone by registering using this online form. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. A replay of the conference call webcast will be archived on the Bank’s website for at least 30 days.

GENERAL INFORMATION

Bank OZK (Nasdaq: OZK) is a regional bank providing innovative financial solutions delivered by expert bankers with a relentless pursuit of excellence. Established in 1903, Bank OZK conducts banking operations in over 240 offices in nine states including Arkansas, Georgia, Florida, North Carolina, Texas, Tennessee, New York, California and Mississippi and had $39.2 billion in total assets as of March 31, 2025. For more information, visit ozk.com.

The Bank files annual, quarterly and current reports, proxy materials, and other information required by the Securities Exchange Act of 1934 with the Federal Deposit Insurance Corporation (“FDIC”), copies of which are available electronically at the FDIC’s website and are also available on the Bank’s investor relations website at ir.ozk.com. Use this online form to receive automated email notifications for these materials.

FORWARD-LOOKING STATEMENTS

This press release and other communications by the Bank and its management may include certain statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the fact that they do not relate strictly to historical or current facts. Forward-looking statements often use words such as “anticipates,” “targets,” “expects,” “hopes,” “estimates,” “intends,” “plans,” “goals,” “believes,” “continue” and other similar expressions or future or conditional verbs such as “will,” “may,” “might,” “should,” “would” and “could.” Forward-looking statements represent the Bank’s current expectations, plans or forecasts of its future results, revenues, liquidity, net interest income, provision for credit losses, expenses, efficiency ratio, capital measures, strategy, deposits, assets, and future business and economic conditions more generally, and other future matters. These statements are not guarantees of future results or performance and involve certain known and unknown risks, uncertainties and assumptions that are difficult to predict and are often beyond the Bank’s control. Actual outcomes and results may differ materially from those expressed in, or implied by, any of these forward-looking statements.

NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) — INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the first quarter 2025 on Tuesday, May 6, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET.

Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE’s Investor Relations website at www.innovate-ir.com. To listen to the live call, please go to the “Investor Relations” section of the Company’s website at least 15 minutes prior to the start of the call to register and download any necessary audio software. For those who are not able to listen to the live broadcast, a replay will be available shortly after the call on the “Investor Relations” portion of the INNOVATE website.

Conference Call Details

Live Call

Domestic Dial-In: 1-877-704-4453
Toll/International: 1-201-389-0920
Conference Replay*
Domestic Dial-In: 1-844-512-2921
Toll/International: 1-412-317-6671
Conference Number: 13753315
*Available approximately three hours after the end of the conference call through May 20, 2025.

About INNOVATE

INNOVATE Corp. is a portfolio of best-in-class assets in three key areas of the new economy – Infrastructure, Life Sciences and Spectrum. Dedicated to stakeholder capitalism, INNOVATE employs approximately 3,100 people across its subsidiaries. For more information, please visit: www.INNOVATECorp.com.

Investor Contact:

Solebury Strategic Communications
Anthony Rozmus
[email protected]
(212) 235-2691

CHASKA, Minn., April 16, 2025 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Lifecore granted a restricted stock unit (“RSU”) award with respect to 45,000 shares of its common stock, an option for 210,000 shares of stock, an RSU for 170,000 shares of common stock, and a performance stock unit (“PSU”) award for up to 370,000 shares of its common stock to Thomas D. Salus, Lifecore’s newly hired chief legal and administration officer. The RSU awards, stock option and PSU award were granted April 14, 2025, pursuant to an employment agreement between Lifecore and Mr. Salus, and as a material inducement to Mr. Salus joining Lifecore as its chief legal and administration officer.

The RSU awards, stock option and PSU award were approved by Lifecore’s compensation committee and were granted as inducement equity awards in accordance with Nasdaq Listing Rule 5635(c)(4) under Lifecore’s Equity Inducement Plan, as amended (the “Inducement Plan”).

The RSU award for 45,000 shares will vest and be settled on the third anniversary of the April 14, 2025, grant date. The stock option has an exercise price equal to Fair Market Value (as defined in the Inducement Plan) on April 14, 2025, and will vest as one-third of the shares on the first anniversary of the grant date and as to 1/36th of the shares on each monthly grant date thereafter, subject to continued employment. The RSU award for 170,000 shares will vest and be settled in three nearly equal installments on each of the first three anniversaries of the April 14, 2025, grant date. Each of the RSU and stock option awards is governed by an award agreement and the Inducement Plan.

The PSU award will vest, if at all, based upon the Performance Price achievement within the five-year performance period as compared to a range of ten prices from $7.50 per share to $35.00 per share. The Performance Price is the average Fair Market Values (as defined in the Inducement Plan) of one share of the company’s common stock over a period of 20 consecutive trading days within the performance period. To the extent the PSU award becomes vested, the company will issue Mr. Salus shares of the company’s common stock on the vesting date in settlement of the PSU award, with 50% of the shares so issued being restricted from transfer until the one-year anniversary of the vesting date. The PSU award is governed by a Performance Stock Unit Award Agreement and the Inducement Plan.

About Lifecore Biomedical

Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.

BRISBANE, Calif., April 16, 2025 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today announced that it has granted inducement to a new non-executive employee under the terms of the 2022 Employment Inducement Award Plan. The equity award was approved on April 11, 2025, in accordance with Nasdaq Listing Rule 5635(c)(4).

The new non-executive employee received an option to purchase 105,000 shares of Annexon common stock. The option carries a ten-year term and an exercise price per share equal to $1.54, which was the closing price of Annexon’s common stock on April 15, 2025, the date of grant, and vests over 4 years, with 25% of the shares underlying the options vesting on the first anniversary of the grant date and an additional 1/48th of the shares vesting monthly thereafter, subject to continued service through the applicable vesting dates.

About Annexon

Annexon Biosciences (Nasdaq: ANNX) is developing therapeutics that stop classical complement-driven neurodegeneration as first-in-kind treatments for millions of people living with serious neuroinflammatory diseases of the body, brain and eye. Our novel scientific approach focuses on C1q, the initiating molecule of classical complement’s potent inflammatory pathway that when misdirected can lead to tissue damage and loss. By targeting C1q, our immunotherapies are designed to stop this neuroinflammatory cascade in disease before it starts. Our pipeline spans three diverse therapeutic areas – autoimmune, neurodegenerative and ophthalmic diseases – and includes targeted investigational drug candidates designed to address the unmet needs of over 8 million people worldwide. Annexon’s mission is to deliver game-changing therapies to patients so that they can live their best lives. To learn more visit annexonbio.com.

Investor Contact:

Joyce Allaire
LifeSci Advisors
[email protected]